Cabaletta Bio Inc (CABA) Live Share Price, Invest From India

Cabaletta Bio Inc Stock Performance

as on December 13, 2025 at 2:29 am IST

Day's Low
Day's High
$2.35
Day's Price Range
$2.42
$2.37
0.84%
Downside
2.11%
Upside
52 Week's Low
52 Week's High
$0.99
52-Week Price Range
$3.67
$2.37
58.41%
Downside
54.85%
Upside

Cabaletta Bio Inc share price movements today

Previous Close: $2.36
Open: $2.37
Volume: 1.5M
Day's Low - High: $2.35 - $2.42
52 Week Low - High: $0.99 - $3.67

Cabaletta Bio Inc Historical Returns

1 Month Return: -3.67 %
3 Month Return: + 28.26 %
1 Year Return: -19.73 %
3 Year Return: -57.09 %
5 Year Return: -84.24 %

Cabaletta Bio Inc Stock Fundamentals & Key Indicators

Check Cabaletta Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$233.0M

EPS (TTM)

-2.068

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-161.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-101.06%

Cabaletta Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cabaletta Bio Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cabaletta Bio Inc	BUY	$233.0M	-84.24%	NA	0.00%
Insmed Incorporated	BUY	$41.6B	389.45%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$53.4B	218.26%	1444.5	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$114.0B	98.92%	31.25	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$77.0B	55.66%	17.42	32.13%

Stock Returns calculator for Cabaletta Bio Inc Stock including INR - Dollar returns

The Cabaletta Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cabaletta Bio Inc investment value today

Current value as on today

₹87,175

Returns

₹12,825

(-12.83%)

Returns from Cabaletta Bio Inc Stock

₹19,388 (-19.39%)

Dollar Returns*

₹6,563 (+6.56%)

Analyst Recommendation on Cabaletta Bio Inc Stock

Based on 17 analysts

BUY

94.12%

Buy

5.88%

Hold

0.00%

Sell

Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Cabaletta Bio Inc. Average target price of $14.12

Cabaletta Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Cabaletta Bio Inc.

What analysts predicted

83.22%UPSIDE

Target Price

$14.12

Current Price

$2.37

Analyzed by

17 Analysts

Target

$14.12

Cabaletta Bio Inc target price $14.12, a slight upside of 83.22% compared to current price of $2.37. According to 17 analysts rating.

Cabaletta Bio Inc Stock’s Investor Sentiment and Interest

Search interest for Cabaletta Bio Inc Stock has increased by 146% in the last 30 days, reflecting an upward trend in search activity.

Time period: November 13, 2025 to December 13, 2025

Change:146% versus previous 30 day period

Cabaletta Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	4	-	-	-	1	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-15	-18	-23	-28	-30	-33	-33	-37	-45	-46
EBITDA	-13	-16	-20	-27	-27	-30	-31	-35	-44	-43
Interest Expense	-	-	1	-	-	-	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-16	-20	-25	-27	-30	-32	-35	-45	-44
Income Tax Expense	0	0	1	0	-	-	0	-	-	-
Net Income	-14	-16	-20	-25	-27	-30	-32	-35	-45	-44
Net Profit Margin	0.00%	0.00%	-520.85%	0.00%	0.00%	0.00%	-1989.38%	0.00%	0.00%	0.00%

Cabaletta Bio Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	0	-	0	-3	-1	-4
Operating Income	-6	-18	-33	-46	-54	-74	-125
EBITDA	-12	-18	-33	-45	-52	-66	-110
Interest Expense	-	-	0	0	1	-	0
Depreciation	-	0	0	0	1	1	1
Income Before Tax	-12	-16	-33	-46	-52	-67	-115
Income Tax Expense	0	-1	0	0	-1	-	-
Net Income	-12	-15	-32	-45	-51	-67	-115
Net Profit Margin	0.00%	0.00%	-324910000000.00%	0.00%	0.00%	0.00%	0.00%

Cabaletta Bio Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-16	-20	-25	-27	-30	-32	-35	-45	-44
Operating Cash Flow	-12	-16	-23	-20	-20	-23	-30	-30	-34
Investing Cash Flow	0	1	0	23	12	12	0	-49	-50
Financing Cash Flow	0	93	6	0	0	4	0	93	0
Change in Cash	-12	77	-17	3	-8	-6	-32	13	-85

Cabaletta Bio Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	-16	-33	-46	-52	-67	-115
Operating Cash Flow	-4	-16	-26	-34	-46	-53	-88
Investing Cash Flow	0	0	-7	5	-27	-22	47
Financing Cash Flow	37	119	0	48	32	187	11
Change in Cash	33	103	-34	20	-40	111	-29

Global Institutional Holdings in Cabaletta Bio Inc

Funds	Holdings
Bain Capital Life Sciences Investors, LLC	10.58%
Adage Capital Partners Gp LLC	9.65%
T. Rowe Price Investment Management,Inc.	7.43%
Jennison Associates LLC	6.58%
Cormorant Asset Management, LLC	5.47%

See all

Insights on Cabaletta Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 908.0% return, outperforming this stock by 965.1%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 171.0% return, outperforming this stock by 190.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CABA stock has moved down by -7.5%

About Cabaletta Bio Inc

cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. the company's lead product candidate is dsg3-caart, which is in phase i clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and hemophilia a with factor viii alloantibodies. its product candidate pipeline also include musk-caart, a preclinical stage product to treat a subset of patients with myasthenia gravis; fviii-caart, a discovery stage product to treat a subset of patients with hemophilia a; and dsg3/1-caart, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. cabaletta bio, inc. has a collaboration with the un

Organisation	Cabaletta Bio Inc
Headquarters	2929 Arch Street, Philadelphia, PA, United States, 19104
Industry	Health Technology
CEO	Dr. Steven A. Nichtberger M.D.
E-voting on shares	Click here to vote

Key Management of Cabaletta Bio Inc

Name	Title
Dr. David J. Chang FACR, M.D., M.P.H.	Chief Medical Officer
Dr. Gwendolyn K. Binder Ph.D.	President of Science & Technology
Dr. Michael C. Milone M.D., Ph.D.	Co-Founder & Co-Chair of Scientific Advisory Board
Dr. Aimee Payne M.D., Ph.D.	Co-Founder & Co-Chair of Scientific Advisory Board
Ms. Heather Harte-Hall M.Sc.	Chief Compliance Officer
Dr. Steven A. Nichtberger M.D.	Co-Founder, Chairman, CEO & President
Mr. Anup Marda M.B.A.	Chief Financial Officer
Dr. Qing Sarah Yuan Ph.D.	Chief Technology Officer
Dr. Samik Basu M.D.	Chief Scientific Officer
Mr. Michael Gerard J.D.	General Counsel & Secretary

FAQs

What is Cabaletta Bio Inc share price today?

Cabaletta Bio Inc share price today is $2.37 as on December 13, 2025 at 2:29 am IST at the close of the market. Cabaletta Bio Inc share today touched a day high of $2.42 and a low of $2.35.

What is the 52 week high and 52 week low for Cabaletta Bio Inc share?

Cabaletta Bio Inc share touched a 52 week high of $3.67 on October 31, 2025 and a 52 week low of $0.99 on April 7, 2025. Cabaletta Bio Inc stock price today i.e. December 13, 2025 at 2:29 am IST is closed at $2.37,which is 35.42% down from its 52 week high and 140.44% up from its 52 week low.

What is Cabaletta Bio Inc's market capitalisation today?

Cabaletta Bio Inc market capitalisation is $0.00T as on December 13, 2025 at 2:29 am IST.

How to invest in Cabaletta Bio Inc Stock (CABA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cabaletta Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cabaletta Bio Inc Shares that will get you 0.6329 shares as per Cabaletta Bio Inc share price of $2.37 per share as on December 13, 2025 at 2:29 am IST.

What is the minimum amount required to buy Cabaletta Bio Inc Stock (CABA) from India?

Indian investors can start investing in Cabaletta Bio Inc (CABA) shares with as little as ₹90.397 or $1 (as of December 13, 2025 at 2:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹903.97 in Cabaletta Bio Inc stock (as per the Rupee-Dollar exchange rate as on December 13, 2025 at 2:37 am IST). Based on Cabaletta Bio Inc share’s latest price of $2.37 as on December 13, 2025 at 2:29 am IST, you will get 4.2194 shares of Cabaletta Bio Inc. Learn more about fractional shares .

What are the returns that Cabaletta Bio Inc has given to Indian investors in the last 5 years?

Cabaletta Bio Inc stock has given -84.24% share price returns and 22.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?